Brief Title
CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)
Official Title
An International, Multi-centre, Randomised, Stratified, Double-blinded, Placebo-controlled, 4-parallel Group Trial Investigating the Efficacy and Safety of Three Different Dose Levels of CRD007 (The AORTA Trial)
Brief Summary
This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.
Study Phase
Phase 2
Study Type
Interventional
Condition
Abdominal Aortic Aneurysm
Intervention
CRD007
Study Arms / Comparison Groups
CRD007 10 mg tablet
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Drug
Eligibility Criteria
Inclusion Criteria: - Infra-renal abdominal aortic aneurysm Exclusion Criteria: - Previous infra-renal aortic surgery - Known diabetes
Gender
All
Ages
50 Years - N/A
Contacts
Henrik Sillesen, MD DMSc, ,
Location Countries
Denmark
Location Countries
Denmark
Administrative Informations
NCT ID
NCT01354184
Organization ID
Cardoz-003
Study Sponsor
RSPR Pharma AB
Study Sponsor
Henrik Sillesen, MD DMSc, Principal Investigator, Rigshospitalet, University of Copenhagen, Denmark
Verification Date
November 2012